Bleeding in Fempatch - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Bleeding, when it was recovered, drug effectiveness, race, and more among people who take Fempatch (estradiol). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Fempatch?

Fempatch has active ingredients of estradiol. eHealthMe is studying from 17 Fempatch users. Check the latest studies of Fempatch.

What is Bleeding?

Bleeding is found to be associated with 1 condition by eHealthMe. Check the latest studies of Bleeding.

On Jun, 28, 2026

2 people who have Bleeding while taking Fempatch were studied.

Severity of Bleeding *:

least: 50 %
moderate: 50 %
severe: 0.0 %
most severe: 0.0 %

When people recovered from Bleeding *:

while on drug: 0.0 %
after off the drug: 100 %
not yet: 0.0 %

How effective is Fempatch:

n/a

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 100 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 0.0 %

Gender of people when taking Fempatch *:

female: 100 %
male: 0.0 %

Age of people when taking Fempatch *:

Conditions people have *:

Urethral Prolapse (circular protrusion of the distal urethra through the external meatus): 1 person, 50.00%
Postmenopause: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fempatch and have Bleeding?

Check whether Bleeding is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Bleeding in Fempatch

How the study uses the data?

The study is based on estradiol (the active ingredients of Fempatch). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.